Publisher Correction: SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway.

Willett BJ., Grove J., MacLean OA., Wilkie C., De Lorenzo G., Furnon W., Cantoni D., Scott S., Logan N., Ashraf S., Manali M., Szemiel A., Cowton V., Vink E., Harvey WT., Davis C., Asamaphan P., Smollett K., Tong L., Orton R., Hughes J., Holland P., Silva V., Pascall DJ., Puxty K., da Silva Filipe A., Yebra G., Shaaban S., Holden MTG., Pinto RM., Gunson R., Templeton K., Murcia PR., Patel AH., Klenerman P., Dunachie S., PITCH Consortium None., COVID-19 Genomics UK (COG-UK) Consortium None., Haughney J., Robertson DL., Palmarini M., Ray S., Thomson EC.

DOI

10.1038/s41564-022-01241-6

Type

Journal article

Journal

Nature microbiology

Publication Date

16/09/2022

Addresses

MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, UK. brian.willett@glasgow.ac.uk.

Keywords

PITCH Consortium, COVID-19 Genomics UK (COG-UK) Consortium

Permalink Original publication